SYTL1 report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	27 studies	30% ± 9%	Explore
mature NK T cell	16 studies	29% ± 12%	Explore
memory B cell	16 studies	22% ± 6%	Explore
ciliated cell	16 studies	33% ± 15%	Explore
CD4-positive, alpha-beta T cell	16 studies	25% ± 9%	Explore
B cell	15 studies	27% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	37% ± 14%	Explore
basal cell	14 studies	33% ± 16%	Explore
regulatory T cell	14 studies	25% ± 9%	Explore
CD8-positive, alpha-beta T cell	13 studies	28% ± 11%	Explore
non-classical monocyte	11 studies	32% ± 13%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	30% ± 9%	Explore
naive B cell	11 studies	23% ± 5%	Explore
T cell	10 studies	20% ± 4%	Explore
CD8-positive, alpha-beta memory T cell	8 studies	22% ± 9%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	8 studies	24% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	8 studies	26% ± 4%	Explore
mucosal invariant T cell	8 studies	28% ± 6%	Explore
plasma cell	7 studies	24% ± 8%	Explore
CD4-positive, alpha-beta memory T cell	7 studies	24% ± 6%	Explore
gamma-delta T cell	7 studies	30% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	28% ± 8%	Explore
epithelial cell	5 studies	34% ± 12%	Explore
classical monocyte	4 studies	25% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	34% ± 5%	Explore
goblet cell	4 studies	25% ± 8%	Explore
club cell	3 studies	19% ± 3%	Explore
respiratory goblet cell	3 studies	21% ± 6%	Explore
exhausted T cell	3 studies	26% ± 11%	Explore
hematopoietic precursor cell	3 studies	28% ± 7%	Explore
plasmablast	3 studies	23% ± 4%	Explore
lymphocyte	3 studies	17% ± 3%	Explore
immature B cell	3 studies	31% ± 8%	Explore
mucus secreting cell	3 studies	22% ± 4%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	30% ± 2%	Explore
keratinocyte	3 studies	24% ± 7%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	25% ± 5%	Explore
double negative thymocyte	3 studies	22% ± 6%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	11 studies	24% ± 3%	Explore
lung	3 studies	29% ± 4%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
pancreas	100%	6716.25	328 / 328	95%	29.07	169 / 178
prostate	92%	8732.34	225 / 245	100%	94.12	501 / 502
lung	94%	1912.67	544 / 578	91%	31.13	1056 / 1155
thymus	82%	1384.41	534 / 653	97%	51.36	584 / 605
bladder	52%	2677.05	11 / 21	86%	51.63	435 / 504
stomach	75%	3397.84	268 / 359	64%	9.37	183 / 286
breast	51%	1080.93	235 / 459	86%	19.09	966 / 1118
esophagus	39%	4246.32	557 / 1445	89%	30.52	162 / 183
lymph node	0%	0	0 / 0	100%	35.30	29 / 29
spleen	100%	6102.12	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	47.40	45 / 45
ureter	0%	0	0 / 0	100%	49.71	1 / 1
peripheral blood	97%	5456.63	905 / 929	0%	0	0 / 0
intestine	31%	786.80	303 / 966	66%	13.11	348 / 527
uterus	5%	223.72	9 / 170	88%	40.89	403 / 459
skin	72%	6583.71	1303 / 1809	18%	3.05	86 / 472
ovary	0%	0	0 / 180	82%	16.13	354 / 430
brain	22%	978.23	581 / 2642	1%	0.11	4 / 705
kidney	10%	165.15	9 / 89	10%	1.92	90 / 901
liver	0%	0	0 / 226	6%	1.23	24 / 406
adrenal gland	0%	3.28	1 / 258	5%	0.71	11 / 230
adipose	3%	44.96	35 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	3%	0.19	2 / 80
blood vessel	1%	30.60	16 / 1335	0%	0	0 / 0
muscle	0%	2.43	2 / 803	0%	0	0 / 0
heart	0%	1.25	1 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0